EyeGate Pharmaceuticals Inc (NASDAQ:EYEG) Stock Falls 22% in a Week: A Good Opportunity?

August 12, 2021

In recent days, there have been many stocks which have recorded considerable losses and one of those is the EyeGate Pharmaceuticals Inc (NASDAQ:EYEG) stock. Over the course of the past week, the stock has been in the middle of a steady selloff and has actually gone down by as much as 22%. On Wednesday, the company was in the news against owing to a key announcement and it may be…

Read More >>

ILUS International Inc. (OTCMKTS:ILUS) Stock Falls 13% in a Week: Where is The Bottom?

August 12, 2021

ILUS International Inc. (OTCMKTS:ILUS) is down 13% in a week. The tech-based enterprises’ acquisition and development company recently completed three acquisitions, including BCD Fire, finalized on April 12, 2021. In addition, the company has also signed two acquisition letters of intent for two US-based firms. Besides BCD Fire currently focusing on supplies, installation, and maintenance of life safety and fixed fire devices in the Middle East, the company is considering…

Read More >>

Is Abeona Therapeutics Inc. (NASDAQ:ABEO) Stock a Good Buy Or Sell After The Recent Correction?

August 12, 2021

Abeona Therapeutics Inc. (NASDAQ: ABEO) stock is down 13% in a month. However, the company recently reported encouraging ABO-102 test results in treating Sanfilippo Syndrome. Sanfilippo mainly affects the CNS causing neurological function deterioration. MRI data from Phase 1/2 Transfer A study showed that ABO-102 increased corpus callosum, amygdala, and grey matter volumes in three patients with Sanfilippo Syndrome Types A at 24 months relative to patients that didn’t receive…

Read More >>

Creative Medical Technology Holdings Inc (CELZ) Stock Suddenly Soars 28%

August 11, 2021

If you are looking into the some of the biggest movers in the market this week then it might be the ideal time to take a peek into Creative Medical Technology Holdings Inc (OTCMKTS:CELZ). The stock experienced heavy action on Tuesday and rallied by as much as 28% as investors piled on to it in a big way. While there was no news about the company on Tuesday, it should…

Read More >>

Lightwave Logic Inc (LWLG) Stock Continues to Fall After The Monster Rally

August 11, 2021

Stocks which experience strong rallies are also prove to be correct sharply due to the tendency of investors to cash in on their profits and that is what has happened with the Lightwave Logic Inc (OTCMKTS:LWLG) stock over the course of the past month. The trend continued in the Lightwave stock on Tuesday as it declined by another 9% on the back of profit taking and took the decline for…

Read More >>

Pixelworks Inc. (NASDAQ:PXLW) Stock Sees Buying Interest At Lower Levels: More to Come?

August 11, 2021

Pixelworks Inc. (NASDAQ:PXLW) jumped 15.5% after announcing 50% sequential and YOY growth in revenue in Q2 2021. The growth is attributable to string projector business recovery and continued growth in mobile revenue. Mobile revenue increased QOQ and YOY driven by enhanced adoption of software and hardware-based visual processing solutions in the increasing number of smartphone launches. ASUS unveiled Zenfone 8 flip and Zonefone 8 flagship phones that incorporate the company’s…

Read More >>

CytoDyn Inc. (OTCMKTS:CYDY) Stock Continues to Struggle At Lower Levels: Now What?

August 11, 2021

CytoDyn Inc. (OTCMKTS:CYDY) is down 6% in a week after announcing approval from Brazilian regulatory agency ANVISA for its previously submitted clinical study protocol to start patient recruitment in the CD17 study for severe coronavirus patients. The company will, in collaboration, conduct the trial with Academic Research Organisation Albert Einstein Israelite Hospital. The study will produce requisite data needed by ANVISA to consider leronlimab’s availability to patients with severe CPVID-19…

Read More >>

ReWalk Robotics (NASDAQ:RWLK) Sees Value Buying After The Recent Fall

August 10, 2021

ReWalk Robotics (NASDAQ:RWLK) jumped 11% after the company reported a quarterly loss of $3.1 million or $0.07 per share in Q2 2021 against the consensus estimate of $0.06 per share. A year ago, the company had a loss per share of $0.22. The earnings in the quarter represent a surprise of -16.67%. The company was expected to post a $0.07 loss per share in the previous quarter, but its loss…

Read More >>